Association study of polymorphisms in the human estrogen receptor alpha gene and prostate cancer risk. 2003

Géraldine Cancel-Tassin, and Alain Latil, and Francis Rousseau, and Philippe Mangin, and Emmanuel Bottius, and Jean-Louis Escary, and Philippe Berthon, and Olivier Cussenot
UroGène, 4 rue Pierre Fontaine, 91058 Evry Cedex, France. g.cancel@cerepp.org

OBJECTIVE Prostate cancer is a very common hormone-related malignancy in Western countries. It is initially dependent on androgen stimulation but in vitro growth of prostate cancer cells are also dependent on estrogen. Our goal was to elucidate if some polymorphisms of estrogen receptor alpha gene might be associated with the risk of prostate cancer. METHODS Using DHPLC techniques, each coding exon of the estrogen receptor alpha gene was screened for new polymorphisms in germline DNA from 96 healthy controls and 96 sporadic prostate cancer cases. Identified polymorphisms were then genotyped and their distribution compared between the two populations. RESULTS Thirteen polymorphisms were identified. A difference was found in the distribution of one newly identified polymorphism, namely a GGGA repeat located in the first intron of the gene. The common wild type genotype consisted of two alleles with five GGGA repetitions (5/5 genotype). Indeed this 5/5 genotype was found in 294/296 controls (99.3%) and 285/294 patients (96.9%; OR, 4.6; 95% CI, 0.99-21.67). Among the nine patients with a different genotype, one was 4/5, seven were 5/6 and one was 6/6. CONCLUSIONS These results suggest that variants of the GGGA polymorphism from the estrogen receptor alpha gene may be associated with an increased risk of developing prostate cancer.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor

Related Publications

Géraldine Cancel-Tassin, and Alain Latil, and Francis Rousseau, and Philippe Mangin, and Emmanuel Bottius, and Jean-Louis Escary, and Philippe Berthon, and Olivier Cussenot
November 2015, Journal of cancer research and clinical oncology,
Géraldine Cancel-Tassin, and Alain Latil, and Francis Rousseau, and Philippe Mangin, and Emmanuel Bottius, and Jean-Louis Escary, and Philippe Berthon, and Olivier Cussenot
April 2000, Carcinogenesis,
Géraldine Cancel-Tassin, and Alain Latil, and Francis Rousseau, and Philippe Mangin, and Emmanuel Bottius, and Jean-Louis Escary, and Philippe Berthon, and Olivier Cussenot
July 2003, Breast cancer research and treatment,
Géraldine Cancel-Tassin, and Alain Latil, and Francis Rousseau, and Philippe Mangin, and Emmanuel Bottius, and Jean-Louis Escary, and Philippe Berthon, and Olivier Cussenot
September 2013, Molecular and cellular biochemistry,
Géraldine Cancel-Tassin, and Alain Latil, and Francis Rousseau, and Philippe Mangin, and Emmanuel Bottius, and Jean-Louis Escary, and Philippe Berthon, and Olivier Cussenot
June 2012, Genetic testing and molecular biomarkers,
Géraldine Cancel-Tassin, and Alain Latil, and Francis Rousseau, and Philippe Mangin, and Emmanuel Bottius, and Jean-Louis Escary, and Philippe Berthon, and Olivier Cussenot
April 2002, Cancer letters,
Géraldine Cancel-Tassin, and Alain Latil, and Francis Rousseau, and Philippe Mangin, and Emmanuel Bottius, and Jean-Louis Escary, and Philippe Berthon, and Olivier Cussenot
July 2005, Zhonghua wai ke za zhi [Chinese journal of surgery],
Géraldine Cancel-Tassin, and Alain Latil, and Francis Rousseau, and Philippe Mangin, and Emmanuel Bottius, and Jean-Louis Escary, and Philippe Berthon, and Olivier Cussenot
August 2003, Molecular carcinogenesis,
Géraldine Cancel-Tassin, and Alain Latil, and Francis Rousseau, and Philippe Mangin, and Emmanuel Bottius, and Jean-Louis Escary, and Philippe Berthon, and Olivier Cussenot
June 2014, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
Géraldine Cancel-Tassin, and Alain Latil, and Francis Rousseau, and Philippe Mangin, and Emmanuel Bottius, and Jean-Louis Escary, and Philippe Berthon, and Olivier Cussenot
May 2014, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
Copied contents to your clipboard!